Omnicell, Inc. reported unaudited impairment changes results for the fourth quarter ended December 31, 2023. For the quarter, the company reported impairment of certain long-lived assets of $1,610,000.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.86 USD | +2.69% | +0.11% | -25.96% |
Apr. 16 | Omnicell, Inc. Announces XT Amplify | CI |
Feb. 29 | Omnicell, Inc. Announces Executive Changes | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-25.96% | 1.28B | |
+4.36% | 32.47B | |
+14.14% | 7.45B | |
+22.93% | 3.89B | |
-16.29% | 3.15B | |
-36.14% | 1.09B | |
-0.13% | 893M | |
-35.42% | 902M | |
-24.12% | 857M | |
-18.47% | 693M |
- Stock Market
- Equities
- OMCL Stock
- News Omnicell, Inc.
- Omnicell, Inc. Reports Unaudited Impairment Changes Results for the Fourth Quarter Ended December 31, 2023